Report Detail
Global Capivasertib Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4702028 |
- 01 June, 2026 |
- Global |
- 79 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Capivasertib market size was valued at US$ 749 million in 2025 and is forecast to a readjusted size of US$ 2761 million by 2032 with a CAGR of 14.4% during review period.
Capivasertib is an oral, highly selective ATP-competitive AKT kinase inhibitor that potently inhibits the activities of AKT1/2/3 isoforms, blocks the abnormal activation of the PI3K/AKT signaling pathway, and thereby inhibits the proliferation, survival, invasion and metastasis of tumor cells. The drug is mainly developed for patients with solid tumors harboring PIK3CA/AKT1/PTEN mutations. Clinically, it is mostly used in combination with endocrine therapy for HR-positive, HER2-negative advanced breast cancer, and is also under investigation in various tumor types such as prostate cancer and colorectal cancer, providing precise targeted therapeutic options for advanced cancer patients with abnormalities in specific signaling pathways.In 2025, global Capivasertib production reached approximately 1.8 million bottles.
Capivasertib has established a core position in the treatment of HR-positive, HER2-negative advanced breast cancer by virtue of its first-mover advantage as the world’s first-in-class AKT inhibitor and a clear biomarker selection strategy. By continuously expanding its pipeline to cover multiple tumor types such as prostate cancer, it has built a broad market space. Its mechanism of action, which precisely targets the PI3K/AKT pathway, aligns perfectly with the mainstream trend of precision and individualized cancer therapy, effectively filling the clinical gap for patients with endocrine resistance. The current market landscape is oligopolistic. As the only approved AKT inhibitor on the market, Capivasertib faces limited direct competition, with only a few similar drugs in late clinical stages. With gradual market access in major global regions, the popularization of companion diagnostics, and the continuous expansion of indications, the drug is rapidly penetrating from second-line breast cancer treatment to more tumor types. It boasts significant long-term commercialization potential and is expected to become a key product driving the growth of AstraZeneca’s oncology business.
This report is a detailed and comprehensive analysis for global Capivasertib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Capivasertib market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Capivasertib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Capivasertib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Capivasertib market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Capivasertib
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Capivasertib market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Capivasertib market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
160 mg
200 mg
Market segment by Combination Therapy
Capivasertib In Combination With Fulvestrant
Capivasertib In Combination With Letrozole
Market segment by Sales Channels
Hospital
Retail
Online
Market segment by Application
HR-Positive, HER2-Negative Advanced Breast Cancer
Metastatic Prostate Cancer
Advanced Colorectal Cancer
Others
Major players covered
AstraZeneca
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Capivasertib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Capivasertib, with price, sales quantity, revenue, and global market share of Capivasertib from 2021 to 2026.
Chapter 3, the Capivasertib competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Capivasertib breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Capivasertib market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Capivasertib.
Chapter 14 and 15, to describe Capivasertib sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Capivasertib Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 160 mg
- 1.3.3 200 mg
- 1.4 Market Analysis by Combination Therapy
- 1.4.1 Overview: Global Capivasertib Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
- 1.4.2 Capivasertib In Combination With Fulvestrant
- 1.4.3 Capivasertib In Combination With Letrozole
- 1.5 Market Analysis by Sales Channels
- 1.5.1 Overview: Global Capivasertib Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
- 1.5.2 Hospital
- 1.5.3 Retail
- 1.5.4 Online
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Capivasertib Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 HR-Positive, HER2-Negative Advanced Breast Cancer
- 1.6.3 Metastatic Prostate Cancer
- 1.6.4 Advanced Colorectal Cancer
- 1.6.5 Others
- 1.7 Global Capivasertib Market Size & Forecast
- 1.7.1 Global Capivasertib Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Capivasertib Sales Quantity (2021-2032)
- 1.7.3 Global Capivasertib Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 AstraZeneca
- 2.1.1 AstraZeneca Details
- 2.1.2 AstraZeneca Major Business
- 2.1.3 AstraZeneca Capivasertib Product and Services
- 2.1.4 AstraZeneca Capivasertib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 AstraZeneca Recent Developments/Updates
3 Competitive Environment: Capivasertib by Manufacturer
- 3.1 Global Capivasertib Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Capivasertib Revenue by Manufacturer (2021-2026)
- 3.3 Global Capivasertib Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Capivasertib by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Capivasertib Manufacturer Market Share in 2025
- 3.4.3 Top 6 Capivasertib Manufacturer Market Share in 2025
- 3.5 Capivasertib Market: Overall Company Footprint Analysis
- 3.5.1 Capivasertib Market: Region Footprint
- 3.5.2 Capivasertib Market: Company Product Type Footprint
- 3.5.3 Capivasertib Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Capivasertib Market Size by Region
- 4.1.1 Global Capivasertib Sales Quantity by Region (2021-2032)
- 4.1.2 Global Capivasertib Consumption Value by Region (2021-2032)
- 4.1.3 Global Capivasertib Average Price by Region (2021-2032)
- 4.2 North America Capivasertib Consumption Value (2021-2032)
- 4.3 Europe Capivasertib Consumption Value (2021-2032)
- 4.4 Asia-Pacific Capivasertib Consumption Value (2021-2032)
- 4.5 South America Capivasertib Consumption Value (2021-2032)
- 4.6 Middle East & Africa Capivasertib Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Capivasertib Sales Quantity by Type (2021-2032)
- 5.2 Global Capivasertib Consumption Value by Type (2021-2032)
- 5.3 Global Capivasertib Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Capivasertib Sales Quantity by Application (2021-2032)
- 6.2 Global Capivasertib Consumption Value by Application (2021-2032)
- 6.3 Global Capivasertib Average Price by Application (2021-2032)
7 North America
- 7.1 North America Capivasertib Sales Quantity by Type (2021-2032)
- 7.2 North America Capivasertib Sales Quantity by Application (2021-2032)
- 7.3 North America Capivasertib Market Size by Country
- 7.3.1 North America Capivasertib Sales Quantity by Country (2021-2032)
- 7.3.2 North America Capivasertib Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Capivasertib Sales Quantity by Type (2021-2032)
- 8.2 Europe Capivasertib Sales Quantity by Application (2021-2032)
- 8.3 Europe Capivasertib Market Size by Country
- 8.3.1 Europe Capivasertib Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Capivasertib Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Capivasertib Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Capivasertib Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Capivasertib Market Size by Region
- 9.3.1 Asia-Pacific Capivasertib Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Capivasertib Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Capivasertib Sales Quantity by Type (2021-2032)
- 10.2 South America Capivasertib Sales Quantity by Application (2021-2032)
- 10.3 South America Capivasertib Market Size by Country
- 10.3.1 South America Capivasertib Sales Quantity by Country (2021-2032)
- 10.3.2 South America Capivasertib Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Capivasertib Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Capivasertib Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Capivasertib Market Size by Country
- 11.3.1 Middle East & Africa Capivasertib Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Capivasertib Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Capivasertib Market Drivers
- 12.2 Capivasertib Market Restraints
- 12.3 Capivasertib Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Capivasertib and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Capivasertib
- 13.3 Capivasertib Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Capivasertib Typical Distributors
- 14.3 Capivasertib Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Capivasertib. Industry analysis & Market Report on Capivasertib is a syndicated market report, published as Global Capivasertib Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Capivasertib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
